Latest stories

  • FDA Approves New Meningococcal Disease Vaccine

    FDA Approves Second Vaccine to Prevent Serogroup B Meningococcal Disease

    The Food and Drug Administration (FDA) has approved a second vaccine for individuals between the ages of 10 and 25 years old to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B: Bexsero. Meningococcal disease refers to any illness caused by the bacteria Neisseria meningitidis. Meningococcus bacteria spread through the exchange of respiratory and […] More

  • Syringe in Hand

    WHO Approves Safe and Effective Meningitis A Vaccine for Infants

    The World Health Organization (WHO) has approved an innovative and affordable meningitis vaccine for infants in sub-Saharan Africa that can rid the area of disease outbreaks through routine vaccination. Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord caused by infection with viruses, bacteria, and other microorganisms. Meningitis A […] More